Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Corriente Biotechnology Partners



Unlock datapoints

Portfolio analytics


News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
The average size of a deal this fund participated in
Portfolio companies 1
Lead investments 0
Exits 1
Key employees Soon
Stages of investment
Private Equity

Areas of investment

  • Biotechnology
  • Therapeutics
  • Biopharma

The typical case for the fund is to invest in rounds with 10 participants. The meaningful sponsors for the fund in investment in the same round are T. Rowe Price, Sigma Capital Group, Rosewood Corporation. In the next rounds fund is usually obtained by AstraZeneca.

We can highlight the next thriving fund investment areas, such as Biopharma, Therapeutics. Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline FibroGen

The increased amount of exits for fund were in 2014. The common things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2005.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Anhui Provincial Emerging Industry Investment Anhui, China, Hefei
Brightbridge Ventures England, London, United Kingdom
Fierce Capital Andalucia, Málaga, Spain
Flightpath Ventures California, San Francisco, United States
Fond fondov District of Zvolen, Region of Banská Bystrica, Slovakia
Guidepost Growth Equity Boston, Massachusetts, United States
Inspire Growth Wales Cardiff, United Kingdom, Wales
IRPC Public Company Bangkok, Krung Thep, Thailand
Key Venture Partners Boston, Massachusetts, United States
Modernization and Technology Development Fund -
New Investment Solutions Liechtenstein, Oberland, Vaduz
Nomadic Japan Chiyoda, Japan
Other Corporate Investors -
Prudential Capital Partners Chicago, Illinois, United States
redpartners gmbh -
Stitch Fix California, San Francisco, United States
Texas Investment Network Dallas, Texas, United States
Transformational Healthcare Opportunity -
YA Global Master SPV Mountainside, New Jersey, United States
Zhongxing Hongtai Touzi China, Shaanxi, Xian Shi


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Corriente Biotechnology Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 100M
Peak activity year 2005
Lead investments 0
Exits 1
Group Appearance index 1.00
Crunchbase icon

Content report

The following text will be sent to our editors: